BioSpace News Archive

Sagimet Biosciences, a clinical-stage biotechnology company, announced today that new results from its Phase 2 FASCINATE-1 trial of TVB-2640 in nonalcoholic steatohepatitis (NASH) will be shared in an oral presentation at The Liver Meeting Digital Experience™ 2020 of the American Association for the Study of Liver Diseases (AASLD) to be held November 13 - 16.

Robert L. Coleman, MD, FACOG, FACS, chief scientific officer of US Oncology Research, has been named an inductee to the 2020 class of the OncLive® Giants of Cancer Care®

CHSI Technologies (CHSI) is a market-leading SaaS platform for Policy and Claims Lifecycle Management, Billing, and Compliance for the commercial insurance industry.

Johnson & Johnson Medical Devices Companies** today announced the United States Food and Drug Administration (FDA) approval of Biosense Webster, Inc.'s THERMOCOOL SMARTTOUCH® SF Ablation Catheter for the treatment of persistent atrial fibrillation (persistent AF)

Trialbee, a leading global technology provider for patient matching and engagement in clinical trials, today announced that the company is providing patient recruitment services to promote patient diversity for vaccine trials funded by the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response.

Atomwise, the leader in using artificial intelligence (AI) for small molecule drug discovery, announced today $2.3M in grant funding for AI-based discovery of antimalarial and anti-tuberculosis therapies from the Bill & Melinda Gates Foundation

Scribe Therapeutics Inc., the company focused on engineering the most advanced platform for CRISPR-based genetic medicine, today unveiled its vision for highly efficient and specific in vivo genome modification

Scribe Therapeutics Inc., the company focused on engineering the most advanced platform for CRISPR-based genetic medicine, today announced a research collaboration with Biogen Inc. (Nasdaq:BIIB) to develop and commercialize CRISPR-based therapies that address an underlying genetic cause of Amyotrophic Lateral Sclerosis (ALS

Helio Health an AI-driven healthcare company focused on commercializing early cancer detection tests from a simple blood draw, today announced the appointment of Wei Li, Ph.D., to its advisory board.

Express Image Digital and Universidad del Sagrado Corazón announced the launch of Express-REZ, a COVID-19 reservations platform that safely manages and tracks campus access including contact tracing.